This paper is in the following e-collection/theme issue:

Cancer Prognosis Models and Machine Learning (14) Decision Support for Health Professionals (1210) Clinical Information and Decision Making (1434) Innovations and Technology in Cancer Care (431)

Published on in Vol 7, No 2 (2021): Apr-Jun

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/25800, first published .
Clinicopathological Criteria Predictive of Recurrence Following Bacillus Calmette-Guérin Therapy Initiation in Non–Muscle-Invasive Bladder Cancer: Retrospective Cohort Study

Clinicopathological Criteria Predictive of Recurrence Following Bacillus Calmette-Guérin Therapy Initiation in Non–Muscle-Invasive Bladder Cancer: Retrospective Cohort Study

Clinicopathological Criteria Predictive of Recurrence Following Bacillus Calmette-Guérin Therapy Initiation in Non–Muscle-Invasive Bladder Cancer: Retrospective Cohort Study

Authors of this article:

Joseph Plasek1 Author Orcid Image ;   John Weissert1 Author Orcid Image ;   Tracy Downs2 Author Orcid Image ;   Kyle Richards2 Author Orcid Image ;   Kourosh Ravvaz1 Author Orcid Image
Article Authors Cited by (4) Tweetations (1) Metrics

Journals

  1. Radovanovic M, Petrovic M, Santric V, Zubelic A. Predictors of response to BCG therapy in non-muscle invasive bladder cancer. Srpski arhiv za celokupno lekarstvo 2022;150(1-2):113 View
  2. Kim J, Lee D, Song W, Lee S, Park S, Nam J. External validation of European Association of Urology NMIBC risk scores to predict progression after transurethral resection of bladder tumor in Korean patients with non-muscle-invasive bladder cancer. Investigative and Clinical Urology 2022;63(5):531 View
  3. Semeniuk-Wojtaś A, Poddębniak-Strama K, Modzelewska M, Baryła M, Dziąg-Dudek E, Syryło T, Górnicka B, Jakieła A, Stec R. Tumour microenvironment as a predictive factor for immunotherapy in non-muscle-invasive bladder cancer. Cancer Immunology, Immunotherapy 2023;72(7):1971 View
  4. Grabe-Heyne K, Henne C, Mariappan P, Geiges G, Pöhlmann J, Pollock R. Intermediate and high-risk non-muscle-invasive bladder cancer: an overview of epidemiology, burden, and unmet needs. Frontiers in Oncology 2023;13 View